I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

Whilst the entire world is battling the second wave of COVID-19, a substantial proportion of
patients who have suffered from the condition in the past months are reporting symptoms …

Objectives/Hypothesis Olfactory dysfunction has been observed as one of the clinical
manifestations in COVID‐19 patients. We aimed to conduct a systematic review and meta …

After rising steadily for decades, global carbon dioxide emissions fell by 6.4%, or 2.3 billion
tonnes, in 2020, as the COVID-19 pandemic squelched economic and social activities …

A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …

Decreased smell function is related to brain health, future mortality, and quality of life. Most
people inflicted with the SARS-CoV-2 virus evidence some measurable smell dysfunction …

Background: The present study aimed to determine the global prevalence of anosmia and
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …

Background: The growing number of COVID-19 patients with long-lasting olfactory disorders
makes it necessary to identify effective treatments that enhance the spontaneous recovery of …

Chemosensory scientists have been skeptical that reports of COVID-19 taste loss are
genuine, in part because before COVID-19 taste loss was rare and often confused with smell …

BackgroundOlfactory dysfunction represents one of the most frequent symptoms of
coronavirus disease 2019, affecting about 70 per cent of patients. However, the …